Tower Research Capital (TRC)’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-44,275
| Closed | -$13.2K | – | 6445 |
|
2023
Q2 | $13.2K | Buy |
44,275
+19,977
| +82% | +$5.95K | ﹤0.01% | 3772 |
|
2023
Q1 | $10K | Buy |
24,298
+11,753
| +94% | +$4.84K | ﹤0.01% | 4451 |
|
2022
Q4 | $15K | Buy |
12,545
+5,972
| +91% | +$7.14K | ﹤0.01% | 3469 |
|
2022
Q3 | $15K | Buy |
6,573
+4,862
| +284% | +$11.1K | ﹤0.01% | 4194 |
|
2022
Q2 | $4K | Sell |
1,711
-1,064
| -38% | -$2.49K | ﹤0.01% | 5305 |
|
2022
Q1 | $27K | Buy |
2,775
+2,450
| +754% | +$23.8K | ﹤0.01% | 3268 |
|
2021
Q4 | $3K | Sell |
325
-785
| -71% | -$7.25K | ﹤0.01% | 5542 |
|
2021
Q3 | $11K | Buy |
1,110
+979
| +747% | +$9.7K | ﹤0.01% | 4279 |
|
2021
Q2 | $1K | Buy |
+131
| New | +$1K | ﹤0.01% | 5308 |
|